Past Meeting | Keystone Symposia

This meeting took place in the past. Here is a list of meetings that are related:
Engineering the Genome (2020Q2)
Genome Engineering: From Mechanisms to Therapies (2019B4)
Precision Genome Editing with Programmable Nucleases (2018B1)

Web Desc
Precision Genome Engineering Organizer(s): J. Keith Joung, Emmanuelle Charpentier and Olivier Danos Date: January 08 - 12, 2017 Location: Beaver Run Resort, Breckenridge, CO, USA Sponsored by Biogen, Editas Medicine, Inc., Merck & Co., Inc., Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc. and Thermo Fisher Scientific Inc. For important information on the coronavirus, please click here Summary of Meeting: Precision genome engineering technologies enable targeted, highly efficient alteration of DNA sequences in living cells or organisms. Given their customizable nature, these technologies promise to be broadly useful both as biomedical research tools and as novel therapeutics for gene-based diseases. Given the rapidity with which this field moves, it is challenging for both newcomers and experts alike to stay updated with all of the latest advances. Furthermore, genome engineering necessarily encompasses a broad range of scientific expertise that includes fundamental mechanisms of DNA repair, basic science studies of bacterial-derived systems that form the basis of many of these technologies, innovations with genome engineering tool platforms, a wide variety of research applications spanning from model organisms to plants and mammalian cells, and pre-clinical and clinical studies aimed at translation into human therapeutics. The goal of this Keystone Symposia meeting is to bring together scientists from academia and industry with diverse but relevant expertise in a setting conducive to discussion of new results and potential collaborative efforts. Invited talks will cover a wide range of topics ranging from fundamental basic science through to clinical translation studies. Attendees of this meeting will have the opportunity to hear about the latest findings in this fast-paced field and to establish collaborations with scientists who have complementary expertise. Scholarship Deadline: September 19 2016 Discounted Abstract Deadline: September 19 2016 Abstract Deadline: October 6 2016 Discounted Registration Deadline: November 9 2016 Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested. Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting: We gratefully acknowledge additional support for this conference from: We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements: Editas Medicine, Inc. Sangamo Therapeutics, Inc. We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

Web Desc

Precision Genome Engineering

Organizer(s): J. Keith Joung, Emmanuelle Charpentier and Olivier Danos

Date: January 08 - 12, 2017
Location: Beaver Run Resort, Breckenridge, CO, USA

Sponsored by Biogen, Editas Medicine, Inc., Merck & Co., Inc., Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc., Sangamo Therapeutics, Inc. and Thermo Fisher Scientific Inc.

For important information on the coronavirus, please click here

Summary of Meeting:

Precision genome engineering technologies enable targeted, highly efficient alteration of DNA sequences in living cells or organisms. Given their customizable nature, these technologies promise to be broadly useful both as biomedical research tools and as novel therapeutics for gene-based diseases. Given the rapidity with which this field moves, it is challenging for both newcomers and experts alike to stay updated with all of the latest advances. Furthermore, genome engineering necessarily encompasses a broad range of scientific expertise that includes fundamental mechanisms of DNA repair, basic science studies of bacterial-derived systems that form the basis of many of these technologies, innovations with genome engineering tool platforms, a wide variety of research applications spanning from model organisms to plants and mammalian cells, and pre-clinical and clinical studies aimed at translation into human therapeutics. The goal of this Keystone Symposia meeting is to bring together scientists from academia and industry with diverse but relevant expertise in a setting conducive to discussion of new results and potential collaborative efforts. Invited talks will cover a wide range of topics ranging from fundamental basic science through to clinical translation studies. Attendees of this meeting will have the opportunity to hear about the latest findings in this fast-paced field and to establish collaborations with scientists who have complementary expertise.

Scholarship Deadline: September 19 2016

Discounted Abstract Deadline: September 19 2016

Abstract Deadline: October 6 2016

Discounted Registration Deadline: November 9 2016

Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Editas Medicine, Inc.

Sangamo Therapeutics, Inc.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program


Sunday, January 08 \| 4:00PM - 8:00PM Arrival and Registration Room: Foyer
Sunday, January 08 \| 6:00PM - 8:00PM Welcome Mixer Room: Foyer No registration fees are used to fund alcohol served at this function.
Monday, January 09 \| 7:00AM - 8:00AM Breakfast Room: Summit Gallery
Monday, January 09 \| 8:00AM - 9:00AM Welcome & Keynote Address Room: Colorado Ballroom Provide an overview of ongoing clinical trials that are based on or utilize genome-editing technologies. Discuss on-going and future challenges to further translation. Speaker 1 of 2 * J. Keith Joung, Massachusetts General Hospital, USA
Monday, January 09 \| 8:00AM - 9:00AM Welcome & Keynote Address Room: Colorado Ballroom Provide an overview of ongoing clinical trials that are based on or utilize genome-editing technologies. Discuss on-going and future challenges to further translation. Speaker 2 of 2 Luigi M. Naldini, San Raffaele Telethon Institute, Italy Precision Genome Engineering of Human Hematopoiesis for Treating Genetic Disease and Cancer
Monday, January 09 \| 9:00AM - 11:30AM (Basic) Science of Recombination & DNA Repair Room: Colorado Ballroom Speaker 1 of 7 * J. Keith Joung, Massachusetts General Hospital, USA
Monday, January 09 \| 9:00AM - 11:30AM (Basic) Science of Recombination & DNA Repair Room: Colorado Ballroom Speaker 2 of 7 David R. Liu, Broad Institute, HHMI, and Harvard University, USA Base Editing: Genome Editing without Double-Stranded DNA Cleavage
Monday, January 09 \| 9:00AM - 11:30AM (Basic) Science of Recombination & DNA Repair Room: Colorado Ballroom Coffee Break
Monday, January 09 \| 9:00AM - 11:30AM (Basic) Science of Recombination & DNA Repair Room: Colorado Ballroom Speaker 4 of 7 Maria Jasin, Memorial Sloan Kettering Cancer Center, USA DNA Repair Mechanisms and Genome Engineering
Monday, January 09 \| 9:00AM - 11:30AM (Basic) Science of Recombination & DNA Repair Room: Colorado Ballroom Speaker 5 of 7 Frederick W. Alt, Boston Children's Hospital, USA Recurrent DNA Break Cluster Genes in Neural Development, Diversification and Disease: Potential Analogies to Lymphocyte Rearrangement Processes
Monday, January 09 \| 9:00AM - 11:30AM (Basic) Science of Recombination & DNA Repair Room: Colorado Ballroom Speaker 6 of 7 Jean-Yves Masson, Laval University Cancer Research Center, Canada Short Talk: Regulation of the Tumor Suppressor PALB2: A Critical Player for Homologous Recombination at a CRISPR/Cas9-Induced DNA Double-Strand Break
Monday, January 09 \| 9:00AM - 11:30AM (Basic) Science of Recombination & DNA Repair Room: Colorado Ballroom Speaker 7 of 7 Katherine S. Pawelczak, NERx Biosciences, USA Short Talk: Chemical Enhancement of CRISPR/Cas9 Mediated Site-Specific Genome Engineering using Novel Inhibitors of the Ku-DNA Interaction
Monday, January 09 \| 11:30AM - 5:00PM On Own for Lunch
Monday, January 09 \| 11:30AM - 1:00PM Poster Setup Room: Breckenridge Ballroom
Monday, January 09 \| 1:00PM - 10:00PM Poster Viewing Room: Breckenridge Ballroom
Monday, January 09 \| 2:30PM - 3:30PM Workshop 1: In vivo Delivery of Genome Editing Nucleases Room: Colorado Ballroom Workshop participants will discuss outstanding issues such as mode of delivery, formulation, routes of administration, dose definition, genotoxicity and immune responses. The goal will be to define the gaps in developing genome editing reagents as injectable drugs. Speaker 1 of 1 * Olivier Danos, REGENXBIO Inc, USA
Monday, January 09 \| 3:30PM - 4:30PM Workshop 2: Ex vivo or in vitro Delivery of Genome Editing N ucleases Room: Colorado Ballroom Speaker 1 of 1 * Luigi M. Naldini, San Raffaele Telethon Institute, Italy
Monday, January 09 \| 4:30PM - 5:00PM Coffee Available Room: Foyer
Monday, January 09 \| 5:00PM - 7:00PM Latest Advances in Genome-Editing Nuclease Technologies I Room: Colorado Ballroom Speaker 1 of 4 * J. Keith Joung, Massachusetts General Hospital, USA
Monday, January 09 \| 5:00PM - 7:00PM Latest Advances in Genome-Editing Nuclease Technologies I Room: Colorado Ballroom Speaker 2 of 4 Edward J. Rebar, Sangamo Therapeutics, Inc., USA New Zinc Finger Nuclease Architectures for Precision Genome Engineering
Monday, January 09 \| 5:00PM - 7:00PM Latest Advances in Genome-Editing Nuclease Technologies I Room: Colorado Ballroom Speaker 3 of 4 Jay Ashok Shendure, University of Washington, USA Applications of Genome Editing in Developmental Biology and Human Genetics
Monday, January 09 \| 5:00PM - 7:00PM Latest Advances in Genome-Editing Nuclease Technologies I Room: Colorado Ballroom Speaker 4 of 4 Amit Choudhary, Harvard Medical School, USA Short Talk: Chemical Control of CRISPR-Cas9 in Cells and Organisms
Monday, January 09 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Breckenridge Ballroom No registration fees are used to fund alcohol served at this function.
Monday, January 09 \| 7:30PM - 10:00PM Poster Session 1 Room: Breckenridge Ballroom
Tuesday, January 10 \| 7:00AM - 8:00AM Breakfast Room: Summit Gallery
Tuesday, January 10 \| 8:00AM - 11:00AM Latest Advances in Genome-Editing Nuclease Technologies II Room: Colorado Ballroom Speaker 1 of 8 * Jennifer A. Doudna, HHMI/University of California, Berkeley, USA
Tuesday, January 10 \| 8:00AM - 11:00AM Latest Advances in Genome-Editing Nuclease Technologies II Room: Colorado Ballroom Speaker 2 of 8 Jonathan S. Weissman, University of California, San Francisco, USA Applications of CRISPR-Cas9-Based Gene Regulatory Proteins
Tuesday, January 10 \| 8:00AM - 11:00AM Latest Advances in Genome-Editing Nuclease Technologies II Room: Colorado Ballroom Speaker 3 of 8 Andrew May, Sana Biotechnology, Inc., USA DNA Repair Outcomes Following Cas9 Double-Stranded Breaks
Tuesday, January 10 \| 8:00AM - 11:00AM Latest Advances in Genome-Editing Nuclease Technologies II Room: Colorado Ballroom Coffee Break
Tuesday, January 10 \| 8:00AM - 11:00AM Latest Advances in Genome-Editing Nuclease Technologies II Room: Colorado Ballroom Speaker 5 of 8 J. Keith Joung, Massachusetts General Hospital, USA Defining, Optimizing and Changing the Specificities of CRISPR-Cas Nucleases
Tuesday, January 10 \| 8:00AM - 11:00AM Latest Advances in Genome-Editing Nuclease Technologies II Room: Colorado Ballroom Speaker 6 of 8 Rolf Turk, Integrated DNA Technologies, USA Short Talk: Efficient Homology-Directed Repair using Long Single-Stranded DNA Templates
Tuesday, January 10 \| 8:00AM - 11:00AM Latest Advances in Genome-Editing Nuclease Technologies II Room: Colorado Ballroom Speaker 7 of 8 Gurumurthy B. Channabasavaiah, University of Nebraska Omaha, USA Short Talk: Easi-CRISPR: A Simple and Efficient Method for Creating Reporter and Conditional Knockout Animal Models
Tuesday, January 10 \| 8:00AM - 11:00AM Latest Advances in Genome-Editing Nuclease Technologies II Room: Colorado Ballroom Speaker 8 of 8 Fuqiang Chen, MilliporeSigma, USA Short Talk: Improvement of CRISPR Activity and Specificity via Proximal Binding of Multiple CRISPR/Cas Systems (proxy-CRISPR)
Tuesday, January 10 \| 11:00AM - 5:00PM On Own for Lunch
Tuesday, January 10 \| 11:00AM - 1:00PM Poster Setup Room: Breckenridge Ballroom
Tuesday, January 10 \| 1:00PM - 10:00PM Poster Viewing Room: Breckenridge Ballroom
Tuesday, January 10 \| 2:30PM - 3:30PM Workshop 3: Genome-Wide Specificities & Off-Target Effects o f Genome Editing Nucleases Room: Colorado Ballroom This workshop will briefly review the various methods that currently exist for determining genome-wide off-target effects. Time will also be provided for a general question and answer session and discussion of best practices for off-target determination. Speaker 1 of 1 * J. Keith Joung, Massachusetts General Hospital, USA
Tuesday, January 10 \| 3:30PM - 4:30PM Workshop 4: Design of Individual gRNAs and Genome-Wide Libra ries of gRNAs for CRISPR-Cas Nucleases Room: Colorado Ballroom This workshop will discuss what you need to know for designing guide RNAs for both small-scale experiments and genome-wide screening. We will look under the hood of available computational tools in order to understand the principles behind the choices baked into these design algorithms. Additionally, we will discuss how the 'optimal' design may vary based on model system and experimental intent. Speaker 1 of 1 * John G. Doench, Broad Institute of MIT and Harvard University, USA
Tuesday, January 10 \| 4:30PM - 5:00PM Coffee Available Room: Foyer
Tuesday, January 10 \| 5:00PM - 7:00PM Biology of CRISPR Systems Room: Colorado Ballroom Updates on cutting-edge basic science studies of CRISPR systems. Not just Cas9 but extend to other aspects of the system (e.g., Cas1/Cas2, sequence-specific ribonucleases). Speaker 1 of 4 * Maria Jasin, Memorial Sloan Kettering Cancer Center, USA
Tuesday, January 10 \| 5:00PM - 7:00PM Biology of CRISPR Systems Room: Colorado Ballroom Updates on cutting-edge basic science studies of CRISPR systems. Not just Cas9 but extend to other aspects of the system (e.g., Cas1/Cas2, sequence-specific ribonucleases). Speaker 2 of 4 Feng Zhang, Broad Institute of MIT and Harvard University, USA Expanding the CRISPR-Cas Genome Engineering Toolbox
Tuesday, January 10 \| 5:00PM - 7:00PM Biology of CRISPR Systems Room: Colorado Ballroom Updates on cutting-edge basic science studies of CRISPR systems. Not just Cas9 but extend to other aspects of the system (e.g., Cas1/Cas2, sequence-specific ribonucleases). Speaker 3 of 4 Eugene V. Koonin, National Institutes of Health, USA Discovery of Novel CRISPR-Cas Systems by Genome and Metagenome Sequence Database Mining and Evolution of Adaptive Immunity in Prokaryotes
Tuesday, January 10 \| 5:00PM - 7:00PM Biology of CRISPR Systems Room: Colorado Ballroom Updates on cutting-edge basic science studies of CRISPR systems. Not just Cas9 but extend to other aspects of the system (e.g., Cas1/Cas2, sequence-specific ribonucleases). Speaker 4 of 4 Joshua Keith Young, Dupont Pioneer, USA Short Talk: Identification and Characterization of Novel Cas9 Endonucleases
Tuesday, January 10 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Breckenridge Ballroom No registration fees are used to fund alcohol served at this function.
Tuesday, January 10 \| 7:30PM - 10:00PM Poster Session 2 Room: Breckenridge Ballroom
Wednesday, January 11 \| 7:00AM - 8:00AM Breakfast Room: Summit Gallery
Wednesday, January 11 \| 8:00AM - 11:00AM Research Applications of Genome & Epigenome Engineering I Room: Colorado Ballroom Speaker 1 of 7 * Barbara J. Meyer, University of California, Berkeley, USA
Wednesday, January 11 \| 8:00AM - 11:00AM Research Applications of Genome & Epigenome Engineering I Room: Colorado Ballroom Speaker 2 of 7 Angelo Lombardo, San Raffaele Telethon Institute for Gene Therapy, Italy Therapeutic Applications of Epigenome Editing
Wednesday, January 11 \| 8:00AM - 11:00AM Research Applications of Genome & Epigenome Engineering I Room: Colorado Ballroom Speaker 3 of 7 Jennifer A. Doudna, HHMI/University of California, Berkeley, USA Mechanism and Delivery of RNA-Guided Genome Engineering Proteins
Wednesday, January 11 \| 8:00AM - 11:00AM Research Applications of Genome & Epigenome Engineering I Room: Colorado Ballroom Coffee Break
Wednesday, January 11 \| 8:00AM - 11:00AM Research Applications of Genome & Epigenome Engineering I Room: Colorado Ballroom Speaker 5 of 7 Alister Funnell, Altius Institute for Biomedical Sciences, USA Short Talk: Functional Characterization of Putative Regulatory Elements by Precision Genome Engineering
Wednesday, January 11 \| 8:00AM - 11:00AM Research Applications of Genome & Epigenome Engineering I Room: Colorado Ballroom Speaker 6 of 7 Robert J. Ihry, Novartis Institutes for BioMedical Research, USA Short Talk: p53 Inhibition Enhances CRISPR/CAS9 Engineering in Human Pluripotent Stem Cells by Blocking DSB-Induced Toxicity
Wednesday, January 11 \| 8:00AM - 11:00AM Research Applications of Genome & Epigenome Engineering I Room: Colorado Ballroom Speaker 7 of 7 Shashank Patel, NCI, National Institutes of Health, USA Short Talk: A Genome-Scale CRISPR Screen to Identify Essential Genes for T Cell Based Cancer Therapies
Wednesday, January 11 \| 11:00AM - 5:00PM On Own for Lunch
Wednesday, January 11 \| 11:00AM - 1:00PM Poster Setup Room: Breckenridge Ballroom
Wednesday, January 11 \| 1:00PM - 10:00PM Poster Viewing Room: Breckenridge Ballroom
Wednesday, January 11 \| 4:30PM - 5:00PM Coffee Available Room: Foyer
Wednesday, January 11 \| 5:00PM - 7:00PM Research Applications of Genome & Epigenome Engineering II Room: Colorado Ballroom Speaker 1 of 5 * Angelo Lombardo, San Raffaele Telethon Institute for Gene Therapy, Italy
Wednesday, January 11 \| 5:00PM - 7:00PM Research Applications of Genome & Epigenome Engineering II Room: Colorado Ballroom Speaker 2 of 5 Barbara J. Meyer, University of California, Berkeley, USA Genome Editing of C. elegans and Other Non-Model Organisms
Wednesday, January 11 \| 5:00PM - 7:00PM Research Applications of Genome & Epigenome Engineering II Room: Colorado Ballroom Speaker 3 of 5 Daniel F. Voytas, University of Minnesota, USA Precise Engineering of Plant Genomes
Wednesday, January 11 \| 5:00PM - 7:00PM Research Applications of Genome & Epigenome Engineering II Room: Colorado Ballroom Speaker 4 of 5 Andrea Crisanti, Imperial College London, UK Building and Testing CRISPR-Based Gene Drives for Population Control in the Malaria Mosquito
Wednesday, January 11 \| 5:00PM - 7:00PM Research Applications of Genome & Epigenome Engineering II Room: Colorado Ballroom Speaker 5 of 5 Alex Marson, University of California, San Francisco, USA Short Talk: Discovery of an Autoimmunity-Associated IL2RA Enhancer by Unbiased Targeting of Transcriptional Activation
Wednesday, January 11 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Breckenridge Ballroom No registration fees are used to fund alcohol served at this function.
Wednesday, January 11 \| 7:30PM - 10:00PM Poster Session 3 Room: Breckenridge Ballroom
Thursday, January 12 \| 7:00AM - 8:00AM Breakfast Room: Summit Gallery
Thursday, January 12 \| 8:00AM - 11:15AM Novel Technologies for Therapeutic Application of Genome Eng ineering Room: Colorado Ballroom Speaker 1 of 7 * Olivier Danos, REGENXBIO Inc, USA
Thursday, January 12 \| 8:00AM - 11:15AM Novel Technologies for Therapeutic Application of Genome Eng ineering Room: Colorado Ballroom Speaker 2 of 7 Vic E. Myer, Atlas Ventures, USA Advancing CRISPR Technologies for Therapeutic Application
Thursday, January 12 \| 8:00AM - 11:15AM Novel Technologies for Therapeutic Application of Genome Eng ineering Room: Colorado Ballroom Speaker 3 of 7 Daniel G. Anderson, Massachusetts Institute of Technology, USA Nucleic Acid Delivery Systems for RNA Therapy and Gene Editing
Thursday, January 12 \| 8:00AM - 11:15AM Novel Technologies for Therapeutic Application of Genome Eng ineering Room: Colorado Ballroom Coffee Break
Thursday, January 12 \| 8:00AM - 11:15AM Novel Technologies for Therapeutic Application of Genome Eng ineering Room: Colorado Ballroom Speaker 5 of 7 Mark A. Kay, Stanford University, USA rAAV-Mediated Genome Editing without the Use of Nucleases
Thursday, January 12 \| 8:00AM - 11:15AM Novel Technologies for Therapeutic Application of Genome Eng ineering Room: Colorado Ballroom Speaker 6 of 7 Bin Li, Ohio State University, USA Short Talk: Lipid-like Nanoparticles for mRNA Delivery in vivo
Thursday, January 12 \| 8:00AM - 11:15AM Novel Technologies for Therapeutic Application of Genome Eng ineering Room: Colorado Ballroom Speaker 7 of 7 Knut Woltjen, CiRA, Kyoto University, Japan Short Talk: Simultaneous Derivation of Disease-Relevant Point-Mutants and Concordant Isogenic Clones from Human Induced Pluripotent Stem Cells
Thursday, January 12 \| 11:15AM - 5:00PM On Own for Lunch
Thursday, January 12 \| 2:30PM - 4:30PM Workshop 5: Ethics & Human Rights Room: Colorado Ballroom Speaker 1 of 3 * George J. Annas, Boston University School of Public Health, USA Why Precision Genome Engineering Should Not Be Used to (Try to) Make a 'Better Baby'
Thursday, January 12 \| 2:30PM - 4:30PM Workshop 5: Ethics & Human Rights Room: Colorado Ballroom Speaker 2 of 3 Peter Dabrock, FAU Erlangen-Nürnberg, Germany “Do Not Throw the Baby Out with the Bathwater” – Societal, Ethical and Governance Challenges of Precision Genome Engineering for Science and Society
Thursday, January 12 \| 2:30PM - 4:30PM Workshop 5: Ethics & Human Rights Room: Colorado Ballroom Speaker 3 of 3 Evelyne Shuster, Veterans Affairs Medical Center, USA Editing the “Book of Life”: Too Early to Prescribe?
Thursday, January 12 \| 4:30PM - 5:00PM Coffee Available Room: Foyer
Thursday, January 12 \| 5:00PM - 6:45PM Therapeutic Applications of Genome Engineering Room: Colorado Ballroom Speaker 1 of 5 * Mark A. Kay, Stanford University, USA
Thursday, January 12 \| 5:00PM - 6:45PM Therapeutic Applications of Genome Engineering Room: Colorado Ballroom Speaker 2 of 5 Andrew M. Scharenberg, Casebia Therapeutics, USA Translational Genome Editing
Thursday, January 12 \| 5:00PM - 6:45PM Therapeutic Applications of Genome Engineering Room: Colorado Ballroom Speaker 3 of 5 Philippe N. Duchateau, Cellectis SA, France TALEN®-Based Targeted Genome Modifications for Improved CAR T-Cell Adoptive Immunotherapy
Thursday, January 12 \| 5:00PM - 6:45PM Therapeutic Applications of Genome Engineering Room: Colorado Ballroom Speaker 4 of 5 Linhong Li, MaxCyte, Inc., USA Short Talk: Mutation Correction of X-linked Chronic Granulomatous Disease
Thursday, January 12 \| 5:00PM - 6:45PM Therapeutic Applications of Genome Engineering Room: Colorado Ballroom Speaker 5 of 5 Sateesh Krishnamurthy, University of Iowa, USA Short Talk: Correction of CFTR Splicing Mutation by Using CRISPR/Cas9 Genome Editing and Non-Homologous End Joining
Thursday, January 12 \| 6:45PM - 7:00PM Meeting Wrap-Up: Outcomes & Future Directions (Organizers) Room: Colorado Ballroom
Thursday, January 12 \| 7:00PM - 8:00PM Social Hour with Lite Bites Room: Breckenridge Ballroom No registration fees are used to fund alcohol served at this function.
Thursday, January 12 \| 8:00PM - 11:00PM Entertainment Room: Breckenridge Ballroom Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources. Novo Nordisk A/S funding is not being used for this function.
Thursday, January 12 \| 8:00PM - 11:00PM Cash Bar Room: Breckenridge Ballroom
Friday, January 13 \| 10:24AM - 10:24AM Departure *Session Chair †Invited, not yet responded.